Article

General Characteristics and Reasons for the Discontinuation of Drug Clinical Trials in Mainland China

2020-12-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Although discontinuation is common in clinical trials, no study has been conducted to analyse the current situation and reasons for the suspension or discontinuation of drug clinical trials in China. This study aims to analyse the general characteristics and reasons for the discontinuation of registered clinical trials in mainland China and to identify the assoc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 82970372-3398-5b7f-8f1f-3a7048930f9e
DOI: 10.21203/rs.3.rs-131119/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

General Characteristics and Reasons for the Discontinuation of Drug Clinical Trials in Mainland ChinaDOI 10.21203/rs.3.rs-131119/v1Read

Trials evaluating drug discontinuation: a scoping review sub-analysis focusing on outcomes and research questionsSemantic proximity Read

WITHDRAWN--a resource for withdrawn and discontinued drugs.Semantic proximity Read

Protocol Complexity and Trial Failure: Predictive Modeling for Early Feasibility Assessment in Drug and Device DevelopmentSemantic proximity Read

Discontinuation of antihypertensive and lipid-lowering medication in primary care: a systematic review of observational data and socio-demographic differencesSemantic proximity Read

Open-Label Placebos for Antidepressant Discontinuation Symptoms: A Series of N-of-1 TrialsSemantic proximity Read

Exploring scalable assessment methods for terminated trials in ClinicalTrials.gov: A cohort analysis of German and Californian trialsSemantic proximity Read

Discontinuation Risk from Adverse Events: Immunotherapy Alone vs. Combined with Chemotherapy: A Systematic Review and Network Meta-analysisSemantic proximity Read

Characteristics of registered systematic reviews on traditional Chinese medicine for COVID-19Semantic proximity Read

Disparities in dosing, drug reduction, and drug discontinuation among US FDA approved tyrosine kinase inhibitorsSemantic proximity Read

Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment.Semantic proximity Read

Systematic Analysis and Quality Evaluation for Pharmacoeconomic Studies on Traditional Chinese MedicinesSemantic proximity Read

Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.Semantic proximity Read